Vitamin D Testing and Treatment for COVID 19

Protocol for Part 1:

• A single blood draw at SCNM to measure levels of vitamin D and other nutrients, comprehensive metabolic panel, and complete blood count with differential
• Completing a medical history/symptom form
• Completing a form about COVID-19 symptoms every 2 weeks for 6 weeks
• Authorization for release of medical records related to COVID 19 testing and/or treatment.

Protocol for Part 2:

• Take a vitamin D supplement daily for two weeks, at a dosage of 10,000 IU/day b.i.d. (age 18-69 years) or 15,000 IU/day t.i.d. (age 70+)
• After two weeks of taking vitamin D, return to SCNM for a blood draw to remeasure levels of vitamin D, comprehensive metabolic panel, and complete blood count with differential. If vitamin D levels are still below 30 ng/ml, continue the dosage for 3 more weeks. If vitamin D levels are 30-49 ng/ml, continue at a dosage of 5000 IU/day. If vitamin D levels are 50+ ng/ml, stop supplementation.
• Completing questionnaires about COVID 19 symptoms at 2, 4, and 6 weeks after treatment begins (5 minutes each time).

Inclusion criteria

for Part 1 (testing):

• Adult age 18 or older
• Previous positive test result for COVID 19
• Able to communicate clearly in English Exclusion Criteria for Part 1 (testing): none

Inclusion criteria

for Part 2 (Vitamin D supplementation)

• Participation in Part 1
• Vitamin D level below 30 ng/ml
• No abnormalities on the comprehensive metabolic panel that are clinically significant to increasing the risk of an adverse reaction to vitamin D supplementation

Exclusion criteria

for Part 2 (Vitamin D supplementation):

• Liver impairment
• Clinical opinion of study physician that vitamin D supplementation could be harmful to the participant.
• Pregnancy
• No symptoms for 2 weeks after positive COVID 19 test
• Recovered from symptoms